All Access Fund
Partners Fund 2021

EmGenisys, Inc

About EmGenisys, Inc

EmGenisys’ SaaS technology offers an objective and consistent analysis of embryo morphokinetic activity to standardize the evaluation of bovine embryos. This system simply involves the assessment of 30 second videos of embryos recorded by the veterinarian and can use these videos to predict embryo health and viability. With more data, veterinarians can choose NOT to transfer embryos with low developmental potential and improve pregnancy outcomes of embryo transfer 20%.